Annoroad Gene Technology (Beijing) Co., Ltd., established in 2012, is a company focusing on molecular-diagnostics-based IVD medical devices and multi-omics life sciences research services. As a platform-type enterprise in the Chinese genome industry, Annoroad has been honored with the multiple qualifications such as the High-tech Enterprise, the Demonstration Center for the Application of the Gene Testing Technology, the National Intellectual Property Advantage Enterprisethe, Laboratory for the Engineering in Beijing, and the Enterprise with the Frontier Technology in Zhongguancun. It boasts a post-doctoral research station.
Annoroad has dedicated itself to the fields of human medical health and life sciences research. Annoroad has established a professional R&D and production platform to actively promote the industrial application of genetic technology and support the development of life sciences.
In the field of medical health, Annoroad has been aligning with technological and industrial advancements, continuously improving clinical testing solutions and driving the development of medical device products based on high-throughput sequencing technology. Annoroad have obtained regulatory approval for multiple medical devices, such as the NextSeq 550AR gene sequencer (GXZZ 20173220330) , the "Fetal Chromosomal Aneuploidy (T21, T18, T13) Detection Kit" (GXZZ 20173400331) , the "Chromosomal Aneuploidy and Microdeletion Detection Kit" (for CNV-seq) (GXZZ 20243400077), contributing to the advancement of clinical genetic testing technologies.
In the field of scientific research services, Annoroad has extensively engaged in scientific research collaborations with colleges and universities. In the fields of single-cell & spatial omics, genomics, etc., Annoroad has formed the distinctive technological advantages to offer exceptional comprehensive solutions for life sciences research.
Since its establishment, Annoroad has prioritized service and continuously optimized high-quality products and services. In the future, Annoroad will become an explorer and leader who continues to provide advanced Genetic testing products and services by adhering to the philosophy of "improve the quality of life with gene technology and innovation".